Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...

Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Persist AI is a drug formulation technology company that developed artificial intelligence-powered Cloud Lab, a remote, cloud ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Quantum systems can simulate molecular interactions at a level of fidelity that classical computers cannot achieve. They can ...